Long-Term Follow-up of Patients Treated With Miltenyi Cell and Gene Therapies
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The goal of this Long-Term Follow-Up Trial is to assess long-term safety and efficacy of Miltenyi CAR T treatment.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Pacjent był leczony terapią komórkową CAR T firmy Miltenyi w poprzednim badaniu co najmniej 12 miesięcy przed włączeniem do tego badania
- •Pacjent wyraził świadomą zgodę na uczestnictwo w badaniu
Simplified criteria — AI translation
Trial details
- Last updated (source)
- October 9, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (7)
Charité Universitätsmedizin Berlin
Berlin, Germany
Universitätsklinikum Köln
Cologne, Germany
Uniklinikum Erlangen
Erlangen, Germany
Universitätsmedizin Göttingen
Göttingen, Germany
Universitätsklinikum Münster
Münster, Germany
Universitätsklinikum Tübingen
Tübingen, Germany
Universitäts-Kinderklinik Würzburg
Würzburg, Germany
Trial contact
Clinical Trial Manager
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 10/10/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.